This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




Text Version  RSS  Subscribe  Unsubscribe  Archive  Media Kit

Home   About AST   Education   Meetings & Events   Public Policy   Contact Us   Jan. 31, 2014

 




SOCIETY NEWS


The AST Cutting Edge of Transplantation is coming up!
AST
Register today to secure your spot at this intimate meeting that focuses on long-term graft survival. CEOT features a truly cutting edge experience: a unique program and a truly interactive experience. More than 30 talks tackle the problem of long-term graft survival through new technology, targets and therapeutics.

Beyond meeting hours, there's a multitude of both on-site activities and things to do in the local area. Take a hike along the hotel's walking trail consider a kayaking or hiking adventure with our Arizona Outback Adventures partner. Get some retail therapy at the nearby outlets or just relax by the pool.

This activity is jointly sponsored by Global Education Group and the American Society of Transplantation. Continuing education credit will be offered for physicians, nurses, pharmacists, and transplant coordinators. For full credit details check here. For information about accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  UCLA Immunogenetics Center

The UCLA Immunogenetics Center (UIC) provides comprehensive testing for organ and tissue transplantation. Transplant testing has a long history at UCLA. HLA typing was pioneered here in the 1960's. The development of the microcytoxicity test in 1964 marked the beginning of international testing and standardization of HLA typing. The UCLA Immunogenetics Center has retained its leadership position in HLA research, and in the development of accompanying diagnostic testing. MORE
 


AST offers webinars live and on demand — free to Members
AST
Feb. 18 at 2 p.m. EST: Complying with New UNOS Living Donor Care Policies (pre-registration is required).
Feb. 21 at 4 p.m. EST: Pathology Webinar for Fellows (pre-registration is required).

On Demand: View archived versions of the following webinars: Update on Kidney Allocation Policy, Update on ID and CMV Consensus Guidelines and more.

All webinars are free for AST members, Timely Topics in Transplantation webinars are $25 each for non-members. There are live webinars in both the Timely Topics in Transplantation and Fellows Live Webinar Series through June of 2014!

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Participate in the AST Institutional Support Program
AST
The AST offers numerous programs for transplant professionals and the support of the community is critically important to the success of the society's programs. By participating in the Institutional Support Program, your center's tax-deductible contribution of $3,000 will increase exposure for your center through electronic marketing, literature, and signage displays, as well as these other valuable benefits. In addition, your institution will be seen throughout the transplant community as having a vested interest in advancing the field of transplantation and improving patient care. Click here to participate in AST's Institutional Support Program, or contact Liz Piegzik, AST Associate Meeting Manager at lpiegzik@myAST.org.

AST thanks the following organizations for their participation in the 2014 Institutional Support Program:
    University of Michigan Transplant Center
    Children's Hospital of Pittsburgh of UPMC

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Become an AST Corporate Affiliate
AST
The AST Corporate Affiliates Program provides an exciting opportunity for companies to support the work of the AST and receive tangible benefits throughout the year.

Benefits of participation include increased visibility, enhanced engagement opportunities, access to new marketing tools, and up-to-date communication about the latest research and advocacy efforts in the field of transplantation. In addition to these benefits, companies participating in this program are invited to meet annually with senior AST leadership to engage in strategic discussions about key issues impacting the field of transplantation.

Click here for additional information, or contact Liz Piegzik, Associate Meeting Manager, at lpiegzik@myAST.org.

AST thanks the following companies for their participation in the 2014 Corporate Affiliates Program:
    Genentech, A Member of the Roche Group
    Novartis Pharmaceuticals
    Roche Diagnostics Corporation
    Veloxis Pharmaceuticals

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Refer new members to AST and enter to win an iPad or AST Bucks!
AST
Talk to your colleagues about the benefits of AST membership that you find most valuable and encourage your colleagues to join today. You'll both strengthen the transplant community and help each other grow personally and professionally!

For each new member that you recruit, your name will be entered to win one of three prizes. You'll receive recognition for your efforts at the 2014 World Transplant Congress (WTC), on the AST website, and in the AST eNews. Encourage your colleagues to complete a membership application by Feb. 28 so that they can register for the WTC at the member discounted registration rate. For further details, please visit: http://www.myAST.org/payitforward.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
 
Astellas is entering its 20th year focusing on transplant immunology. Today we remain steadfast in our commitment to advancing the field. Tomorrow we will seek new possibilities to help improve the transplant experience. Together. Please visit astellas.us
 


Discounts for members on AST books
AST
AJT publisher Wiley offers AST members a 35 percent discount on purchases of the AST Handbook on Transplant Infections and the AST Primer on Transplantation, 3rd Edition. To receive the discount, go to myast.org/publications, log in, and view the member discount code.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


TRANSPLANT NEWS


Fecal microbiota transplantation for refractory clostridium difficile colitis in solid organ transplant recipients
American Journal of Transplantation (login required)
Fecal microbiota transplantation has been shown to be safe and efficacious in individuals with refractory Clostridium difficile. It has not been widely studied in individuals with immunosuppression due to concerns about infectious complications. Study authors describe two solid organ transplant recipients, one lung and one renal, in this case report that both had resolution of their diarrhea caused by C. difficile after FMT.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Sarcopenia is a prognostic factor in living donor liver transplantation
Liver Transplantation (login required)
The aims of this study were to investigate sarcopenia as a novel predictor of mortality and sepsis after living donor liver transplantation (LDLT) and to evaluate the effects of early enteral nutrition on patients with sarcopenia. Two hundred four patients undergoing preoperative computed tomography within the month before LDLT were retrospectively evaluated.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Crossmatch-positive liver transplantation in patients receiving thymoglobulin-rituximab induction
Transplantation (login required)
Positive crossmatch (CM) in liver transplantation (LT) is associated with worse outcomes. Role of induction immunosuppression in this setting remains to be studied. In this study, 1,000 consecutive LT patients receiving rabbit antithymocyte globulin±rituximab induction were studied.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Study: Pain identifies squamous cell carcinoma in organ transplant recipients
American Journal of Transplantation (login required)
Organ transplant recipients (OTR) are at high risk for cutaneous squamous cell carcinomas (SCC). In this study, authors aimed to define clinically meaningful patient-reported warning signals predicting the presence of invasive SCC. Patient-reported signs and symptoms of 812 consecutively biopsied skin lesions from 410 OTR were determined by questionnaire and physical examination and related to the subsequent biopsy-proven diagnoses.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Relation between pretransplant magnesemia and the risk of new onset diabetes after transplantation within the first year of kidney transplantation
Transplantation (login required)
New-onset diabetes after transplantation (NODAT) is a frequent condition associated with a poor outcome. In kidney transplantation, hypomagnesemia is a frequent posttransplant complication and has been associated with calcineurin inhibitors use. Previous studies have analyzed the relationship between posttransplant hypomagnesemia and the risk of NODAT and provided conflicting conclusions. Authors conducted an observational study to analyze the relationship between pretransplant magnesemia (Mg) and the risk of NODAT within the first year of kidney transplantation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


The extent and predictors of waiting time geographic disparity in kidney transplantation in the US
Transplantation (abstract)
Waiting time to deceased donor kidney transplant varies greatly across the United States. This variation violates the final rule, a federal mandate, which demands geographic equity in organ allocation for transplantation. This retrospective analysis looks at the United States Renal Data System and United Network for Organ Sharing database from 2000 to 2009.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: A meta-analysis of observational studies
Transplantation (login required)
A number of cohort studies have compared the outcomes of liver transplantation and liver resection in hepatocellular carcinoma patients. However, the effects of LT versus LR remain unclear. Researchers searched electronic databases and reference lists for relevant articles published before February 2013. The primary endpoints were pooled using random-effects models to model potential heterogeneity, including overall survival, disease-free survival and recurrence rate.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Acute cellular rejection: Impact of donor-specific antibodies and C4d (Transplantation)
Successful treatment for graft-versus-host disease after pancreas transplantation (Clinical Transplantation )
Dendritic cells of myeloid lineage: the masterminds behind acute allograft rejection (Current Opinion in Organ Transplantation)
T-cell migration to vascularized organ allografts (Current Opinion in Organ Transplantation)

Don't be left behind. Click here to see what else you missed.


An international survey of cytomegalovirus prevention and treatment practices in intestinal transplantation
Transplantation (login required)
An electronic survey was sent to IT programs registered with the Intestinal Transplant Association. Proportions were analyzed for categorical variables; means and SDs were analyzed for continuous variables.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Growth following solid organ transplantation in childhood
Pediatric Transplantation (login required)
One of the ultimate goals of successful transplantation in pediatric solid organ transplant recipients is the attainment of optimal final adult height. This manuscript will discuss the attainment of height following solid organ transplantation in pediatric recipients of kidney, liver, heart, lung and small bowel transplantation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Drug shows promise for posttransplant new-onset diabetes
Renal & Urology News
In a small study, sitagliptin showed short-term efficacy and safety in the treatment of new-onset diabetes after renal transplantation. Dr. Thea Anine Strom Halden of Oslo University Hospital in Norway, and colleagues studied 19 long-term stable renal transplant recipients with new-onset diabetes after transplantation. The patients had a median age of 67 years. The investigators randomized patients to receive either sitagliptin 50-100 mg/day for four weeks followed by a sitagliptin-free period of four weeks or vice versa. Results showed that sitagliptin significantly increased first- and second-phase insulin secretion and lowered fasting and postprandial plasma glucose levels. The drug was well tolerated, and the researchers observed no effect on endothelial function and plasma markers of cardiovascular risk and no serious adverse events.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



AST eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Courtney Hodges, Content Editor, 972.402.2604   
Contribute news


This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

Recent issues
Jan. 17, 2014
Jan. 10, 2014
Feb. 3, 2014
Jan. 3, 2014






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063